Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLPT NYSE:INSP NASDAQ:LIVN NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLPTClearPoint Neuro$27.32+7.6%$16.15$9.76▼$30.10$721.35M1.191.81 million shs927,221 shsINSPInspire Medical Systems$80.91+3.7%$82.87$70.77▼$216.01$2.31B1.16965,240 shs697,310 shsLIVNLivaNova$54.10+0.7%$54.39$32.48▼$58.91$2.93B0.95463,488 shs279,915 shsWRBYWarby Parker$21.77+0.3%$25.97$13.63▼$29.73$2.28B2.11.66 million shs1.44 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLPTClearPoint Neuro+7.64%+4.00%+143.93%+143.49%+102.97%INSPInspire Medical Systems+3.69%+4.30%+1.31%-37.49%-59.90%LIVNLivaNova+0.69%+4.48%-1.64%+24.20%+0.99%WRBYWarby Parker+0.27%-1.78%-23.56%-11.19%+31.55%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLPTClearPoint Neuro$27.32+7.6%$16.15$9.76▼$30.10$721.35M1.191.81 million shs927,221 shsINSPInspire Medical Systems$80.91+3.7%$82.87$70.77▼$216.01$2.31B1.16965,240 shs697,310 shsLIVNLivaNova$54.10+0.7%$54.39$32.48▼$58.91$2.93B0.95463,488 shs279,915 shsWRBYWarby Parker$21.77+0.3%$25.97$13.63▼$29.73$2.28B2.11.66 million shs1.44 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLPTClearPoint Neuro+7.64%+4.00%+143.93%+143.49%+102.97%INSPInspire Medical Systems+3.69%+4.30%+1.31%-37.49%-59.90%LIVNLivaNova+0.69%+4.48%-1.64%+24.20%+0.99%WRBYWarby Parker+0.27%-1.78%-23.56%-11.19%+31.55%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLPTClearPoint Neuro 2.50Moderate Buy$19.67-28.01% DownsideINSPInspire Medical Systems 2.40Hold$148.0082.92% UpsideLIVNLivaNova 2.50Moderate Buy$59.7110.38% UpsideWRBYWarby Parker 2.45Hold$25.2015.75% UpsideCurrent Analyst Ratings BreakdownLatest CLPT, LIVN, WRBY, and INSP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/15/2025INSPInspire Medical SystemsTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$125.00 ➝ $90.0010/10/2025INSPInspire Medical SystemsRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$150.0010/8/2025CLPTClearPoint NeuroWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025INSPInspire Medical SystemsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)10/8/2025LIVNLivaNovaWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025WRBYWarby ParkerWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/7/2025INSPInspire Medical SystemsEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$150.00 ➝ $125.0010/6/2025WRBYWarby ParkerThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$27.00 ➝ $31.0010/1/2025LIVNLivaNovaThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy ➝ Neutral$55.0010/1/2025LIVNLivaNovaThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold$55.009/27/2025CLPTClearPoint NeuroWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 10/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLPTClearPoint Neuro$31.39M24.74N/AN/A$0.92 per share29.70INSPInspire Medical Systems$802.80M2.98$1.77 per share45.66$23.01 per share3.52LIVNLivaNova$1.25B2.36$4.27 per share12.67$24.31 per share2.23WRBYWarby Parker$771.32M2.97$0.34 per share63.92$3.35 per share6.50Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLPTClearPoint Neuro-$18.91M-$0.81N/AN/AN/A-66.15%-94.44%-51.58%11/6/2025 (Estimated)INSPInspire Medical Systems$53.51M$1.7346.7725.132.436.17%10.38%8.93%11/3/2025 (Estimated)LIVNLivaNova$63.23M-$3.89N/A17.23N/A-16.13%14.57%6.91%11/5/2025 (Estimated)WRBYWarby Parker-$20.39M-$0.07N/A217.71N/A-1.12%-0.79%-0.41%11/6/2025 (Estimated)Latest CLPT, LIVN, WRBY, and INSP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/6/2025Q3 2025CLPTClearPoint Neuro-$0.20N/AN/AN/A$9.60 millionN/A11/6/2025Q3 2025WRBYWarby Parker$0.09N/AN/AN/A$224.49 millionN/A11/5/2025Q3 2025LIVNLivaNova$0.91N/AN/AN/A$342.32 millionN/A11/3/2025Q3 2025INSPInspire Medical Systems-$0.11N/AN/AN/A$220.39 millionN/A8/12/2025Q2 2025CLPTClearPoint Neuro-$0.20-$0.21-$0.01-$0.21$9.20 million$9.22 million8/6/2025Q2 2025LIVNLivaNova$0.84$1.05+$0.21$0.50$332.20 million$352.50 million8/4/2025Q2 2025INSPInspire Medical Systems$0.22$0.45+$0.23-$0.12$214.50 million$217.09 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLPTClearPoint NeuroN/AN/AN/AN/AN/AINSPInspire Medical SystemsN/AN/AN/AN/AN/ALIVNLivaNovaN/AN/AN/AN/AN/AWRBYWarby ParkerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLPTClearPoint Neuro1.467.306.45INSPInspire Medical SystemsN/A6.144.84LIVNLivaNova0.311.291.09WRBYWarby ParkerN/A2.552.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLPTClearPoint Neuro30.08%INSPInspire Medical Systems94.91%LIVNLivaNova97.64%WRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipCLPTClearPoint Neuro6.11%INSPInspire Medical Systems2.30%LIVNLivaNova0.29%WRBYWarby Parker18.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLPTClearPoint Neuro11028.43 million26.69 millionOptionableINSPInspire Medical Systems1,24629.57 million28.89 millionOptionableLIVNLivaNova2,90054.60 million54.44 millionOptionableWRBYWarby Parker3,780105.19 million86.00 millionOptionableCLPT, LIVN, WRBY, and INSP HeadlinesRecent News About These CompaniesWarby Parker to Announce Third Quarter 2025 Financial Results November 6, 2025October 16, 2025 | theglobeandmail.comWarby Parker Inc. (NYSE:WRBY) Receives Average Recommendation of "Hold" from AnalystsOctober 14, 2025 | americanbankingnews.comWarby Parker Inc. (NYSE:WRBY) Given Consensus Rating of "Hold" by BrokeragesOctober 14, 2025 | marketbeat.comEstimating The Intrinsic Value Of Warby Parker Inc. (NYSE:WRBY)October 8, 2025 | finance.yahoo.comWarby Parker (NYSE:WRBY) Receives Sell (D-) Rating from Weiss RatingsOctober 8, 2025 | marketbeat.comGoldman Sachs Maintains Warby Parker (WRBY) Buy RecommendationOctober 7, 2025 | msn.com18,527 Shares in Warby Parker Inc. $WRBY Bought by Wealth Enhancement Advisory Services LLCOctober 7, 2025 | marketbeat.comDeep Dive Into Warby Parker Stock: Analyst Perspectives (8 Ratings)October 6, 2025 | benzinga.comWarby Parker: Excellent Management Of Tariffs, Accelerating GrowthOctober 6, 2025 | seekingalpha.comThe Goldman Sachs Group Issues Positive Forecast for Warby Parker (NYSE:WRBY) Stock PriceOctober 6, 2025 | marketbeat.comVaughan Nelson Investment Management L.P. Buys 1,137,970 Shares of Warby Parker Inc. $WRBYOctober 4, 2025 | marketbeat.comWarby Parker Is Still Worth Buying At This PriceSeptember 26, 2025 | seekingalpha.comStrs Ohio Takes Position in Warby Parker Inc. $WRBYSeptember 24, 2025 | marketbeat.comPallas Capital Advisors LLC Takes $229,000 Position in Warby Parker Inc. $WRBYSeptember 23, 2025 | marketbeat.comWarby Parker (NYSE:WRBY) CEO Neil Harris Blumenthal Sells 500 SharesSeptember 20, 2025 | insidertrades.comInsider Selling: Warby Parker (NYSE:WRBY) CEO Sells 41,084 Shares of StockSeptember 16, 2025 | insidertrades.comWarby Parker (WRBY) Rose Following the Partnership Announcement with GoogleSeptember 11, 2025 | insidermonkey.comJoel Cutler Sells 35,000 Shares of Warby Parker (NYSE:WRBY) StockSeptember 11, 2025 | insidertrades.comEvercore ISI Reaffirms Their Hold Rating on Warby Parker (WRBY)September 9, 2025 | theglobeandmail.comWarby Parker Inc. (WRBY) Presents At Goldman Sachs 32nd Annual Global Retailing Conference 2025 TranscriptSeptember 4, 2025 | seekingalpha.comWarby Parker Announces Participation in the Goldman Sachs 32nd Annual Global Retailing ConferenceAugust 28, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCLPT, LIVN, WRBY, and INSP Company DescriptionsClearPoint Neuro NASDAQ:CLPT$27.32 +1.94 (+7.64%) Closing price 10/20/2025 04:00 PM EasternExtended Trading$27.44 +0.13 (+0.46%) As of 10/20/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.Inspire Medical Systems NYSE:INSP$80.91 +2.90 (+3.71%) Closing price 10/20/2025 03:59 PM EasternExtended Trading$80.80 -0.11 (-0.13%) As of 10/20/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.LivaNova NASDAQ:LIVN$54.10 +0.37 (+0.69%) Closing price 10/20/2025 04:00 PM EasternExtended Trading$54.06 -0.04 (-0.07%) As of 10/20/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.Warby Parker NYSE:WRBY$21.77 +0.07 (+0.33%) Closing price 10/20/2025 03:59 PM EasternExtended Trading$21.78 +0.00 (+0.02%) As of 10/20/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet Waymo’s Global Expansion Strengthens the Case for GOOGL Stock Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock Meta vs OpenAI: Is Sora a True Threat to Meta's Dominance? Institutions Are Fueling CrowdStrike’s Next Leg Higher This AI Chip Giant Could Be the Market’s Next Big Winner JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall? Microsoft & NVIDIA Unveil GB300 Supercomputer as AI Race Heats Up Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
